BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Applied DNA Sciences, Inc. (APDN) SigNature® DNA Sends UK Thieves to Jail for 53 Years


8/13/2012 8:52:20 AM

STONY BROOK, NY--(Marketwire - August 13, 2012) - Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced today that its SigNature® DNA product has once again helped to send criminals to prison. Forensic evidence, including SigNature DNA-marked stolen cash from Loomis cash boxes, was used to link the criminals to a crime spree spanning eight cash-in-transit (CIT) crimes in the United Kingdom. The sentences for the ten criminals total 53 years.

Detective Constable Will Roscoe, leader of Operation Tejat, an investigation launched by the Metropolitan Police Flying Squad based at the Barnes office, London, said: "This was a prolific gang of robbers specifically targeting cash in transit vans and custodians. I have no doubt they would have continued this course of action if it were not for a detailed and targeted operation to identify and arrest them. Their convictions and sentences represent a significant success for the Barnes Flying Squad and the MPS in our Total War on Crime."

Cash in transit (CIT) businesses transport and store cash and service ATMs. In the UK alone, an estimated £ 500 billion is transported each year, or £ 1.4 billion per day. The nature of this business makes CIT an attractive target for criminals, and as a result the industry invests millions each year in security equipment and devices. Attacks against CIT carriers in the UK has been reduced significantly over recent years due to the investments made in security and a close relationship between law enforcement agencies, customers and the industry. The impact of SigNature DNA has been notable in the CIT industry where APDN has been working with Loomis UK, a provider of specialist cash management services that use the most advanced security and technological solutions available.

As reported in the Guardian on July 27th, the now-convicted gang-of-10 stole more than £ 100,000 in eight robberies and attempted robberies of CIT vans in Mitcham, Streatham, Wallington and Croydon between January 3, 2011 and June 10, 2011. On all occasions, force was used against security guards to snatch cash boxes, which were later broken into and the cash contents stolen. Much of the cash was marked with SigNature DNA. Detectives carried out surveillance and forensic work, leading to the arrest of the ten robbers on or shortly after August 24, 2011. Nine of the ten pleaded guilty to robbery at Kingston Crown Court. One pleaded not guilty but was convicted of conspiracy to rob.

About Applied DNA Sciences

APDN is a provider of botanical-DNA based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature® DNA and smartDNA, our principal anti-counterfeiting and product authentication solutions that essentially cannot be copied, provide a forensic chain of evidence and can be used to prosecute perpetrators.

The statements made by APDN may be forward-looking in nature. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 8, 2011 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


MEDIA CONTACT:
Mitchell Miller
646-543-3373
fax: 631-444-8848

INVESTOR CONTACT:
Debbie Bailey
631-444-8090,
fax: 631-444-8848

FCMN Contact:
Email Contact

PROGRAM CONTACT:
Tony Benson
+44 (0) 7552 429341

Web site: http://www.adnas.com
Twitter: @APDN, @APDNInvestor



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->